Cheng SH - Search Results

1

A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells.

Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH, Cheng SH, Tsang CM, Tsao SW, Chan AT. Wong JH, et al. Among authors: cheng sh. Cancer Lett. 2010 Jan 1;287(1):23-32. doi: 10.1016/j.canlet.2009.05.022. Epub 2009 Jun 26. Cancer Lett. 2010. PMID: 19560263

2

Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma.

Ng MH, To KW, Lo KW, Chan S, Tsang KS, Cheng SH, Ng HK. Ng MH, et al. Among authors: cheng sh. Clin Cancer Res. 2001 Jun;7(6):1724-9. Clin Cancer Res. 2001. PMID: 11410512

3

Recurrent chromosomal rearrangements involving breakpoints 3p21 and 19q13 in Chinese IgD multiple myeloma detected by G-banding and multicolor spectral karyotyping: a review of IgD karyotype literature.

Ng MH, Wong N, Tsang KS, Cheng SH, Chung YF, Lo KW. Ng MH, et al. Among authors: cheng sh. Hum Pathol. 2001 Sep;32(9):1016-20. doi: 10.1053/hupa.2001.27122. Hum Pathol. 2001. PMID: 11567234

4

Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.

Ng MH, Wong N, Lau TT, Tsang KS, Cheng SH, Chan NP, Tang SH, Lei KI, Leung Y. Ng MH, et al. Among authors: cheng sh. Oncol Rep. 2003 May-Jun;10(3):587-91. Oncol Rep. 2003. PMID: 12684628

5

Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression.

Cheng SH, Ng MH, Tsang KS, Lau KM, Chan JC, Liu HS, Chu RW, Poon CS, Ng HK. Cheng SH, et al. Int J Oncol. 2004 May;24(5):1141-8. Int J Oncol. 2004. PMID: 15067335

6

Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.

Wong WS, Cheng KC, Lau KM, Chan NP, Shing MM, Cheng SH, Chik KW, Li CK, Ng MH. Wong WS, et al. Among authors: cheng kc, cheng sh. Leuk Res. 2007 Feb;31(2):235-8. doi: 10.1016/j.leukres.2006.04.015. Epub 2006 Jun 13. Leuk Res. 2007. PMID: 16777224

7

Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients.

Lau KM, Cheng SH, Lo KW, Lee SA, Woo JK, van Hasselt CA, Lee SP, Rickinson AB, Ng MH. Lau KM, et al. Among authors: cheng sh. Br J Cancer. 2007 Feb 26;96(4):617-22. doi: 10.1038/sj.bjc.6603580. Epub 2007 Jan 30. Br J Cancer. 2007. PMID: 17262084 Free PMC article.

8

The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines.

Ma BB, Lui VW, Hui EP, Lau CP, Ho K, Ng MH, Cheng SH, Tsao SW, Chan AT. Ma BB, et al. Among authors: cheng sh. Invest New Drugs. 2010 Aug;28(4):413-20. doi: 10.1007/s10637-009-9269-x. Epub 2009 May 27. Invest New Drugs. 2010. PMID: 19471857

9

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response.

Ma BB, Lui VW, Poon FF, Wong SC, To KF, Wong E, Chen H, Lo KW, Tao Q, Chan AT, Ng MH, Cheng SH. Ma BB, et al. Among authors: cheng sh. Invest New Drugs. 2010 Jun;28(3):326-33. doi: 10.1007/s10637-009-9316-7. Epub 2009 Sep 16. Invest New Drugs. 2010. PMID: 19756373 Free PMC article.

10

Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1.

Hong B, Lui VW, Hui EP, Lu Y, Leung HS, Wong EY, Cheng SH, Ng MH, Mills GB, Chan AT. Hong B, et al. Among authors: cheng sh. Biochem Pharmacol. 2010 Mar 15;79(6):842-52. doi: 10.1016/j.bcp.2009.10.021. Epub 2009 Oct 30. Biochem Pharmacol. 2010. PMID: 19879857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,009 results

Search Page

Filters